‘Grey’s Anatomy’ star joins campaign to educate parents on children’s cough-cold dosing
The Consumer Healthcare Products Association unveiled a series of public service announcements Tuesday featuring Chandra Wilson, a star of the ABC drama “Grey’s Anatomy.”
The PSAs concern the safe use of children’s OTC oral cough and cold medicines and are designed to provide parents and caregivers with tips to follow when administering the medicines to children and are part of CHPA’s “Treat with Care” campaign.
“As parents, we’re in charge of our children’s health, and as a mother of three, I take this responsibility very seriously,” Wilson said. “Many of us rely on OTC cough and cold medicines to help our children feel better when they’re sick.”
The medicines are safe and effective for children when used as directed, CHPA said, but could carry risks if used or stored incorrectly.
“For decades, parents have relied on pediatric OTC cough and cold medicines to relieve their children’s cough and cold symptoms,” CHPA president Linda Suydam said. “When used properly, these medicines are safe and effective, and the ‘Treat with Care’campaign underscores the importance of continuing to use these medicines safely in children.”
Price, value sway U.S. consumers when choosing OTC medicines
SCHAUMBURG, Ill. Consumers in the United States place more importance on price and value when buying OTC medications compared to global consumers, according to an online survey conducted by The Nielsen Company and the Association of the European Self-Medication Industry.
Results of the survey, released Monday, showed that Americans ranked second in considering price of OTC products important, at 30 percent, compared to 33 percent of consumers in Japan. At the same time, 17 percent of global consumers consider price. A quarter of American consumers consider whether the product is a good value for money, compared to 15 percent of global consumers.
“With increasing medical costs and a fragile economy, the U.S. consumer is more price and value centric than ever,” NielsenHealth managing director Matt Dumas said. ”These findings highlight the rising importance of generic drugs in the U.S. market, which is underscored by low OTC product loyalty scores versus global markets.”
The survey included 28,253 Internet users in 51 markets in Europe, Asia Pacific, North America and the Middle East and was conducted between April and May.
Bowel-friendly iron pill to be released OTC
CHICAGO A dual-action iron supplement pill with almost no gastrointestinal side effects will soon be available without prescription, the maker has said.
Alaven announced the supplement, Bifera, at the American Dietetic Association Monday. The supplement provides protein-based and plant-based iron and will become available early next year.
“When patients are deficient in iron, their organs aren’t performing at maximum capacity, and they experience a decrease in energy,” the supplement?s product manager, Autumn Akin, said. “Similar to a hybrid car, Bifera is small, efficient and produces energy quickly without unwanted side effects, like nausea and constipation.”